174 related articles for article (PubMed ID: 11145190)
1. Effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on plasma glucose and glucagon levels of rats.
Sugimoto Y; Yamada J
Biol Pharm Bull; 2000 Dec; 23(12):1521-3. PubMed ID: 11145190
[TBL] [Abstract][Full Text] [Related]
2. The 5-HT(2C/2B) receptor agonist, m-chlorophenylpiperazine, increases plasma glucagon levels in rats.
Yamada J; Sugimoto Y
Eur J Pharmacol; 2000 Oct; 406(1):153-7. PubMed ID: 11011047
[TBL] [Abstract][Full Text] [Related]
3. Effects of the 5-HT2C/2B receptor agonist 1-(3-chlorophenyl) piperazine on plasma glucose levels of rats.
Sugimoto Y; Yamada J; Yoshikawa T; Horisaka K
Eur J Pharmacol; 1996 Jun; 307(1):75-80. PubMed ID: 8831107
[TBL] [Abstract][Full Text] [Related]
4. Hyperglycemia induced by the 5-HT receptor agonist, 5-methoxytryptamine, in rats: involvement of the peripheral 5-HT2A receptor.
Yamada J; Sugimoto Y; Yoshikawa T; Horisaka K
Eur J Pharmacol; 1997 Apr; 323(2-3):235-40. PubMed ID: 9128844
[TBL] [Abstract][Full Text] [Related]
5. p-Chloroamphetamine, a serotonin-releasing drug, elicited in rats a hyperglycemia mediated by the 5-HT1A and 5-HT2B/2C receptors.
Yamada J; Sugimoto Y; Yoshikawa T
Eur J Pharmacol; 1998 Oct; 359(2-3):185-90. PubMed ID: 9832390
[TBL] [Abstract][Full Text] [Related]
6. Serotonin 2A receptor regulation of striatal neuropeptide gene expression is selective for tachykinin, but not enkephalin neurons following dopamine depletion.
Basura GJ; Walker PD
Brain Res Mol Brain Res; 2001 Aug; 92(1-2):66-77. PubMed ID: 11483243
[TBL] [Abstract][Full Text] [Related]
7. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
8. Effects of the non-selective 5-HT receptor agonist, 5-carboxamidotryptamine, on plasma glucose levels in rats.
Yamada J; Sugimoto Y; Noma T; Yoshikawa T
Eur J Pharmacol; 1998 Oct; 359(1):81-6. PubMed ID: 9831297
[TBL] [Abstract][Full Text] [Related]
9. Central and peripheral mechanisms in the stimulation of adrenocortical secretion by the 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane.
Welch JE; Saphier D
J Pharmacol Exp Ther; 1994 Sep; 270(3):918-28. PubMed ID: 7932204
[TBL] [Abstract][Full Text] [Related]
10. Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task.
Koskinen T; Ruotsalainen S; Puumala T; Lappalainen R; Koivisto E; Männistö PT; Sirviö J
Neuropharmacology; 2000 Jan; 39(3):471-81. PubMed ID: 10698013
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
12. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.
Willins DL; Meltzer HY
J Pharmacol Exp Ther; 1997 Aug; 282(2):699-706. PubMed ID: 9262333
[TBL] [Abstract][Full Text] [Related]
13. The 5-HT1A receptor agonist 8-hydroxy-2-di-n-(propylamino)tetralin (8-OH-DPAT) induces hyperglucagonemia in rats.
Sugimoto Y; Kimura I; Watanabe Y; Yamada J
Biol Pharm Bull; 2001 Oct; 24(10):1191-4. PubMed ID: 11642331
[TBL] [Abstract][Full Text] [Related]
14. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat.
Chaouloff F; Laude D; Baudrie V
Eur J Pharmacol; 1990 Oct; 187(3):435-43. PubMed ID: 2127400
[TBL] [Abstract][Full Text] [Related]
15. Regulation of 5-HT(2A) receptor mRNA levels and binding sites in rat frontal cortex by the agonist DOI and the antagonist mianserin.
Anji A; Kumari M; Sullivan Hanley NR; Bryan GL; Hensler JG
Neuropharmacology; 2000 Aug; 39(11):1996-2005. PubMed ID: 10963743
[TBL] [Abstract][Full Text] [Related]
16. Differential involvement of 5-HT(2A) receptors in the discriminative-stimulus effects of cocaine and methamphetamine.
Munzar P; Justinova Z; Kutkat SW; Goldberg SR
Eur J Pharmacol; 2002 Feb; 436(1-2):75-82. PubMed ID: 11834249
[TBL] [Abstract][Full Text] [Related]
17. Modulation by 5-hT2A receptors of aggressive behavior in isolated mice.
Sakaue M; Ago Y; Sowa C; Sakamoto Y; Nishihara B; Koyama Y; Baba A; Matsuda T
Jpn J Pharmacol; 2002 May; 89(1):89-92. PubMed ID: 12083749
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
Albinsson A; Palazidou E; Stephenson J; Andersson G
Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
[TBL] [Abstract][Full Text] [Related]
19. Enhanced responsivity of 5-HT(2A) receptors at warm ambient temperatures is responsible for the augmentation of the 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia.
Zhang G; Tao R
Neurosci Lett; 2011 Feb; 490(1):68-71. PubMed ID: 21172407
[TBL] [Abstract][Full Text] [Related]
20. Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI.
Zhang Y; Damjanoska KJ; Carrasco GA; Dudas B; D'Souza DN; Tetzlaff J; Garcia F; Hanley NR; Scripathirathan K; Petersen BR; Gray TS; Battaglia G; Muma NA; Van de Kar LD
J Neurosci; 2002 Nov; 22(21):9635-42. PubMed ID: 12417689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
